We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEN icon
976
Penumbra
PEN
$12.8B
$106K 0.01%
446
+275
+161% +$62.5K
BBVA icon
977
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$106K 0.01%
10,866
+1,792
+20% +$17.7K
CRK icon
978
Comstock Resources
CRK
$3.94B
$105K 0.01%
5,786
+399
+7% +$5.53K
BNTX icon
979
BioNTech
BNTX
$23.5B
$105K 0.01%
923
+300
+48% +$34.2K
BP icon
980
BP
BP
$107B
$105K 0.01%
3,548
+312
+10% +$9.37K
CATY icon
981
Cathay General Bancorp
CATY
$4.24B
$104K 0.01%
2,188
+657
+43% +$31.7K
GMED icon
982
Globus Medical
GMED
$11.2B
$104K 0.01%
1,258
+370
+42% +$29.2K
SUI icon
983
Sun Communities
SUI
$14.7B
$104K 0.01%
846
+19
+2% +$2.43K
FLS icon
984
Flowserve
FLS
$10.2B
$104K 0.01%
1,807
+290
+19% +$16.6K
SRPT icon
985
Sarepta Therapeutics
SRPT
$1.77B
$104K 0.01%
854
+185
+28% +$22.7K
KD icon
986
Kyndryl
KD
$3.05B
$104K 0.01%
2,999
+580
+24% +$16.9K
ACWX icon
987
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
$103K 0.01%
1,984
+670
+51% +$36.6K
NTNX icon
988
Nutanix
NTNX
$16.9B
$103K 0.01%
1,691
+332
+24% +$21.7K
MTG icon
989
MGIC Investment
MTG
$6.25B
$103K 0.01%
4,363
+11
+0.3% +$275
GTES icon
990
Gates Industrial Corporation Ltd.
GTES
$7.15B
$103K 0.01%
5,026
+1,130
+29% +$22.8K
FDL icon
991
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.84B
$103K 0.01%
2,565
ALE
992
DELISTED
Allete
ALE
$103K 0.01%
1,593
-199
-11% -$12.8K
CVBF icon
993
CVB Financial
CVBF
$3.99B
$103K 0.01%
4,820
+453
+10% +$9.58K
WTM icon
994
White Mountains Insurance
WTM
$5.13B
$103K 0.01%
53
+4
+8% +$7.56K
FCFS icon
995
FirstCash
FCFS
$8.78B
$103K 0.01%
994
+94
+10% +$10.1K
IYG icon
996
iShares US Financial Services ETF
IYG
$2.2B
$103K 0.01%
1,323
WPC icon
997
W.P. Carey
WPC
$16.4B
$103K 0.01%
1,889
-555
-23% -$31.6K
XLU icon
998
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$103K 0.01%
2,718
+134
+5% +$5.32K
POWL icon
999
Powell Industries
POWL
$7.71B
$103K 0.01%
1,389
-9
-0.6% -$804
ABG icon
1000
Asbury Automotive
ABG
$3.85B
$102K 0.01%
421
+28
+7% +$6.86K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.